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Abstract: Intracellular protein delivery is an invaluable tool for biomedical research, as it
enables fundamental studies of cellular processes and creates opportunities for novel therapeutic
development. Protein delivery reagents such as cell penetration peptides (CPPs) and protein
transduction domains (PTDs) are frequently used to facilitate protein delivery. Herein, synthetic
polymer mimics of PTDs, called PTDMs, were studied for their ability to self-assemble in aqueous
media as it was not known whether self-assembly plays a role in the protein binding and delivery
process. The results obtained from interfacial tensiometry (IFT), transmission electron microscopy
(TEM), transmittance assays (%T), and dynamic light scattering (DLS) indicated that PTDMs do not
readily aggregate or self-assemble at application-relevant time scales and concentrations. However,
additional DLS experiments were used to confirm that the presence of protein is required to induce
the formation of PTDM-protein complexes and that PTDMs likely bind as single chains.
Keywords: block copolymers; interfacial tension (IFT); self-assembly; TEM; protein transduction
domain mimics; antibodies; dynamic light scattering (DLS)
1. Introduction
The initial discovery of a cell-membrane penetrating protein called HIV-1 tat in 1988 has given
rise to the modern field of cell-penetrating peptides (CPPs) and protein transduction domains (PTDs),
which now include cell-membrane-penetrating transporters such as transportan, Pep-1, penetratin,
CADY, and MPG among others [1–9]. CPPs and PTDs are often utilized for biomedical applications
given that their cell penetrating function facilitates the delivery of exogenous biologics, such as
nucleic acids and proteins, into cells both in vitro and in vivo [10]. The field of polymer chemistry
has capitalized on key CPP structure-activity studies to produce effective polymer mimics, known as
CPPMs and PTDMs. The guanidinium groups in CPPs and PTDs are the most frequently mimicked
feature, appearing often in their synthetic polymer counterparts [4,11–16].
Though other groups have designed CPPMs and PTDMs through a variety of polymerization
techniques, our group has focused specifically on PTDM design by leveraging a ring-opening
metathesis polymerization (ROMP) platform [4,13,16–19]. Dual functional, oxanorbornene
ROMP-monomers and the well-controlled nature of the polymerization have allowed for the synthesis
of highly tuned and optimized amphiphilic block copolymer PTDMs, where parameters such
as guanidinium density, hydrophobic side chain density, overall hydrophobicity, block length,
block ratios, and block segregation can be manipulated [20–28]. Since the first PTDM developed
by our group in 2008, we have thoroughly explored the PTDM synthetic parameter space and used
those well-defined polymers to deliver bioactive siRNA and functional protein cargo, including
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antibodies, into difficult-to-transfect T cells, among other cell types [20,21,23,29–31]. Additionally,
our amphiphilic block copolymer PTDMs have consistently found greater success as delivery reagents
than their cationic homopolymer counterparts [24,29].
Amphiphilic block copolymers are especially known for their ability to self-assemble in solution
as well as in the bulk [32]. Often water-soluble, amphiphilic copolymers are characterized for their
surfactant-like qualities, using interfacial tensiometry (IFT), and for their propensity to self-assemble,
using dynamic light scattering (DLS) or transmission electron microscopy (TEM) [33–36]. Given that
our PTDMs have distinct hydrophilic and hydrophobic blocks and that our PTDMs are used in
applications involving aqueous media, a reasonable assumption would be that these polymers
undergo some self-assembly or aggregation. For that reason, our low dispersity (Đ ~1.1) block
copolymer PTDMs (~6000 g/mol for PTDM1) [21], which have molecular weights higher than that of
small molecule surfactants, like sodium dodecyl sulfate (SDS) (288.38 g/mol), but lower than that of
traditional amphiphilic block copolymers, have been studied for their ability to self-assemble by DLS
previously, but at elevated concentrations (2.5 mg/mL or 5 mg/mL), far above application-relevant
conditions [20]. Questions still remain about PTDM self-assembly and whether this has any bearing
on their ability to bind and deliver protein cargo. For example, in a previous report, PTDM1 (structure
shown below) was present at a concentration of ~36 µg/mL to form complexes with enhanced green
fluorescent protein (EGFP) in solution before dilution down to ~7 µg/mL, with respect to PTDM1,
for the protein delivery step [21]. Due to these low concentrations, which complicate characterization
techniques such as light scattering, the formation of PTDM-protein complexes has been characterized
using transmittance (%T) assays by our group, as well as by using fluorescence-based binding assays
that enable the calculation of dissociation constants [21,28,31,37].
Herein, the ability of our PTDMs to spontaneously self-assemble is revisited at
application-relevant concentrations. A combination of characterization techniques, including pendant
drop IFT, DLS, %T assays, and TEM, were employed to investigate the propensity of our PTDMs
to self-assemble. Overall, our findings suggest that PTDMs are not inclined to form robust and
stable self-assembled structures at low, application-relevant concentrations, though some data seem to
indicate that PTDMs are capable of forming aggregates in phosphate buffered saline (PBS) over long
time periods.
2. Materials and Methods
2.1. Materials
Dimethyl sulfoxide (DMSO) was purchased from Fisher Scientific. PBS buffer, 10×, pH 7.4,
was purchased from Thermo Fisher Scientific, Inc. (Waltham, MA, USA) which was diluted to 1× with
Milli-Q® water and adjusted to pH 7.2 with TITRISTAR® 0.1 N hydrochloric acid from EMD Chemical,
Inc. (Gibbstown, NJ, USA) and an Accumet® Basic AB15 pH meter from Fisher Scientific prior to
use. The Milli-Q® water used for all TEM, IFT, Plate Reader, and DLS experiments was obtained
by further purifying house reverse osmosis (RO) water using a Millipore Milli-Q® UF plus system
(Burlington, MA, USA). After storage, the pH of this Milli-Q water was measured to be between 4
and 5 by pH indicator strips (pH range of pH 0–14 from EMD Chemical Inc.). All materials required
for the synthesis of PTDM1 have been previously reported [20,21,29]. For interfacial tensiometry
(IFT) measurements, Optima® HPLC grade Toluene was obtained from Fisher Scientific. In addition,
an optical glass cuvette with a total cell volume of 3.5 mL was obtained from Science Outlet (Hong
Kong Special Adminstrative Region, Hong Kong, China) and a flat-ended metal needle (22 gauge,
0.718 mm nominal outer diameter with a Kel-F hub) was obtained from the Hamilton Company (Reno,
NV, USA). Plastic, disposable, NORM-JECT® 1 mL syringes came from Henke-Sass, Wolf GmbH
(Tuttlingen, Germany). For transmission electron microscopy (TEM) experiments, carbon films on
copper grids (400 mesh, ultra-thin) were purchased from Electron Microscopy Sciences (Hatfield, PA,
USA). In addition, KIMTECH® Kimwipes Science Brand came from Kimberly Clark Professional
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(Roswell, GA, USA) and anti-mouse IgG (whole molecule)-FITC produced in goat, affinity isolated
antibody (IgG-FITC) was purchased from Sigma-Aldrich (St. Louis, MO, USA) as an aqueous buffered
solution. For plate reader experiments, 96 well UltraCruz® UV plates with clear, flat bottoms were
purchased from Santa Cruz Biotechnology (Dallas, TX, USA). For dynamic light scattering (DLS)
experiments, disposable poly(styrene) cuvettes, with a cell volume capacity of 4.5 mL, were purchased
from Fisher Scientific. In addition, green PES syringe filters (size 13 mm, pore size 0.45 µm) came from
the Restek Corporation (Bellefonte, PA, USA). PARAFILM® “M” laboratory film came from Pechiney
Plastic Packaging (Bemis NA, Neenah, WI, USA).
2.2. Instrumentation and Software
IFT experiments were conducted using a Contact Angle System OCA 15plus made by Dataphysics
Instruments GmbH (Filderstadt, Germany). Interfacial tension as a function of time was calculated
by fitting the suspended droplet shape to the Young-Laplace equation using a SCA22 “surface and
interfacial tension” software module. TEM images were collected using a FEI Technai T12 TEM
equipped with a TVIPS TemCam-F216 camera and using EM-Menu4 software (version 4.0.9.83,
Gauting, Germany). DLS experiments were conducted using a Malvern Instruments Zetasizer
Nano ZSP and data analysis was done with the corresponding zetasizer software (version 7.11,
Westborough, MA, USA). Light scattering was measured at a back-scattering angle of 173◦ (the NIBS
default instrument setting). The standard operating procedure (SOP) used for all DLS experiments
included setting poly(norbornene) as the “material” where the refractive index (RI) was estimated to be
1.5. The “dispersant” selected in the SOP was either water (instrument preset, RI = 1.330) or a “complex
solvent”, PBS, (RI = 1.332, viscosity = 0.9071 cP), which was custom built using estimates provided by
the software solvent builder module, where the primary component selected was water and the minor
components consisted of sodium chloride (0.1552 mol/L), sodium phosphate dibasic (0.0030 mol/L),
and sodium phosphate (0.0011 mol/L) as a substitute for potassium phosphate monobasic, which was
the actual component in the PBS. The disposable cuvette option DTS0012 was also selected in the SOP.
All plate reader experiments were conducted using a BioTek SynergyMx plate reader with Gen5™
software (version 1.10.8, Winooski, VT, USA). For %T assays, the pathlength correction feature was
selected in the software. For the collection of UV-visible spectra, the software was programmed to scan
every wavelength in increments of 1 nm between 230 nm to 750 nm (read speed normal setting).
2.3. PTDM Selection and Stock Solution Preparation
PTDM1 was chosen for this study as the model PTDM, since its synthesis and characterization
had been previously reported [20,21,29]. The theoretical molecular weight of PTDM1, based on its
idealized, stoichiometric structure is 5899.25 g/mol which was used for calculations to create a 1 mM
stock solution in DMSO [21,29]. The PTDM1 stock dissolved in DMSO was stored at −20 ◦C, causing
it to freeze. Prior to use, the stock solution was allowed to thaw and reach room temperature after
which time it was vortexed for ~30 s. For all experiments, the 1 mM PTDM1 stock solution in pure
DMSO was always diluted with either Milli-Q® water or 1× PBS to obtain the lower concentrations
required for a given experiment, a process which always led to residual amounts of DMSO in the final
PTDM1 solution depending on the extent of dilution. For example, all 10 µM solutions of PTDM1 had
1% v/v residual DMSO whereas 100 µM solutions of PTDM1 had 10% v/v residual DMSO.
2.4. Pendant Drop Interfacial Tensiometry (IFT)
PTDM1 solutions at 1, 10, and 100 µM were prepared via serial dilution of a 1 mM PTDM1 stock
solution in pure DMSO. DMSO was added to the 1 and 10 µM PTDM1 solutions such that all PTDM1
solutions tested contained 10% DMSO v/v. Control solutions of pure Milli-Q® water and Milli-Q®
water with 10% v/v DMSO were also prepared. A flat-ended needle and a 1 mL disposable, plastic
syringe were used to draw up the aqueous phase. The 1 mL syringe was then loaded into the syringe
pump portion of the instrument where it was secured. Manual use of the syringe pump was required
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to expel air from the tip of the needle prior to submersion of the needle into a Toluene ambient phase
(~3 mL), which was contained within an optically clear, glass cuvette. After proper alignment and
focusing of the instrument camera on the needle, the automated syringe pump control was used
to dispense a droplet such that a large, tear-shaped droplet hung from the needle. The following
reference was consulted with respect to obtaining a proper drop shape and size [38]. Usually, the first
droplet was discarded, and the formation of a second, suitable droplet was followed by data collection
(droplet imaging with the instrument/camera set to take 1 measurement per second). The software
kept time such that t = 0 on the raw data plots refers to when the data collection started, not the
time at which the droplet was first formed, but only equilibrium IFT values away from t = 0 were
reported and used for calculations. The temperature of the room (usually between 21 and 22 ◦C)
and the manufacturer-reported outer diameter of the needle was input into the software interface,
along with the identity of both phases using presets in the instrument software, which then set the
density of the phases based on their identity. The manufacturer-reported outer needle diameter of
0.718 mm, which was also verified manually with calipers to be between 0.71–0.72 mm, was used as
the input parameter.
Each trial run was stopped once equilibrium values for IFT had been achieved as shown in
Figures S1–S5. A single, average IFT value for a given sample was generated by averaging all data
points obtained from all trials from the stable, equilibrium portion of the curve as discussed in
Figures S1–S5. The change in IFT, denoted as ∆IFT, was calculated as IFTSample − IFTControl in an
attempt to show by how much each surfactant sample, including examples from literature, changed
the IFT relative to their respective controls and each other. All IFT values used in calculations for
all surfactants from literature, all PTDM1 solutions, and their respective controls are summarized in
Table S1.
2.5. Transmission Electron Microscopy (TEM)
A 1× PBS solution with 1% v/v DMSO was prepared. In separate experiments, a 10 µM
PTDM1 solution in Milli-Q® water which contained 1% v/v residual DMSO was prepared from
the aforementioned 1 mM stock described above. A 200 nM IgG-FITC antibody solution was also
prepared by diluting a commercially obtained 1.1 mg/mL antibody (Ab) solution with Milli-Q® water.
The theoretical Ab molecular weight used for the calculation was 151,479.64 g/mol, which took into
account the number of FITC fluorescent dyes on the Ab, which was 3.8 on average, according to
the manufacturer.
To prepare a dried TEM grid for imaging, a clean grid was taken with TEM tweezers and held
while a pipette was used to dispense a 3 µL sized droplet onto the grid. After 30 s, the excess liquid
on the grid was removed by touching the liquid on the surface of the grid with the edge of a clean
KIMTECH® Kimwipe. The grid was stored on filter paper and covered by a plastic box and then
allowed to dry overnight in ambient conditions. After one night of drying, dried grids were stored in a
separate TEM grid box until they were imaged. All grids were imaged using a FEI Technai T12 TEM.
2.6. Dynamic Light Scattering (DLS)
All DLS data were collected using a Malvern Zetasizer Nano ZSP set to measure back-scattered
light at an angle of 173◦. PTDM1 solutions at 10 µM in either PBS or Milli-Q® water were prepared by
diluting the aforementioned PTDM1 1 mM DMSO stock solution. The total volume of all solutions
used for DLS experiments was set at 1 mL to satisfy the minimum solution level required by the
instrument. All 1 mL solutions were filtered using 2 mL syringes to pass the sample solutions through
poly(ethersulfone) (PES) filters. The excess air in the 2 mL syringe was also passed through the filter
so that liquid left in the filter could be pushed into cuvette and recovered. All solutions were filtered
directly into disposable poly(styrene) cuvettes, which had been washed both on the inside and outside
with filtered methanol several times and blown dry with filtered air. All cuvettes were stored in
clean foil pouches overnight prior to experiments to allow for complete drying and to prevent dust
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accumulation. For the DLS experiments done after a ~24 h waiting period, the sample preparation was
identical except that after filtering directly into cleaned cuvettes, the top of the cuvettes was wrapped
in PARAFILM® to prevent evaporation of the samples. The samples were carefully wrapped in foil
pouches and stored upright for ~24 h prior to DLS experiments.
2.7. DLS Titration Experiment
For the DLS titration experiment, a solution of IgG-FITC was prepared fresh at 200 nM,
with respect to protein, from the commercially obtained protein solution. The molarity of the antibody
solution was calculated by using 150,000 g/mol, as the base molecular weight of IgG, and by taking
into account the molecular weight added by the conjugation of the FITC dye molecules, which varies
depending on the lot/batch of protein. The product information and lot number specification sheets
were consulted to determine at what concentration the original antibody solution was provided and
how many dyes on average there were per protein. Once a solution was prepared, it was filtered
directly into a prepared PS disposable cuvette as described above.
One milliliter of antibody-only solution was prepared in PBS, buffered at pH ~7.2, and DLS
measurements were made using the aforementioned software parameters, except the generic “protein”
“material” instrument preset was selected this time. This included the parameters RI (refractive
index) = 1.45 and absorbance = 0.001. Three independent DLS experiments were done with three
antibody-only solutions first to determine the size distribution by intensity and number as a baseline
for the titration. As for the titration experiments, a fresh 200 nM antibody-only solution was prepared
immediately before each titration. A baseline reading of the antibody-only solution was taken first to
confirm that it matched the antibody positive control data. After the initial reading, aliquots of the
PTDM1-only solution (100%) DMSO were added incrementally to the antibody-only solution and
pipetted up and down and stirred gently. After mixing, the same original cuvette was checked for dust
on the sides and placed back in the DLS instrument for measurements. This process was repeated until
measurements had been taken for the following 10 µL additions and one final 20 µL resulting in 10 then
20 then 30, 40, 50, 60, 70, 80, and finally 100 total µL of added PTDM1-only solution. The experiment
was stopped at 100 total µL PTDM1-only solution added because this amount of the solution resulted
in a final concentration of PTDM1 of ~90.9 µM which was past the saturation point studied in the
corresponding fluorescence quenching experiments. The titration experiment was repeated a second
time. Additional information about this experiment can be found in the Supplementary Materials
(Table S2).
2.8. Transmittance (%T) Assays and UV-Visible Spectra
%T time course curves and UV-visible spectra were obtained using a BioTek plate reader and UV
transparent 96-well plates. PTDM1 solutions at a concentration of 10 µM (1% v/v residual DMSO)
in both Milli-Q® water and PBS with a total volume of 200 µL were made in the wells of the plate
along with two control solutions, one being a 200 µL total volume solution of pure Milli-Q® water
and another being a 200 µL total volume solution of pure PBS. Prior to %T assays, UV-visible spectra
were obtained at 25 ◦C for all solutions with optical density measurements taken every 1 nm between
230 and 750 nm. Transmittance (%T) was then determined by first measuring the absorbance (A) of
four wavelengths of light (300, 400, 500, and 700 nm) that were passed through the solutions of the
wells in the plate. The first measurement taken was considered t = 0, after which time the instrument
was programmed to delay for two hours before taking another measurement, which was deemed
t = 2 h. This cycle of %T measurements of all wells followed by a two-hour delay was repeated
12 times, such that the total delay time accrued was 24 h. The total experiment time took more than
24 h when the time of taking the measurements and reading the initial UV-visible spectra were taken
into account. During this total time of over 24 h, the plate was stored immobile in the plate reader
and was not disturbed. In terms of data processing, the absorbance (A) values of the control solutions
were subtracted out of the sample solutions wells at all time points as background, and the remaining
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absorbance (A) due to the PTDM1 sample solution was converted to %T with the following equation:
%T = 10(2−A). All plate reader experiments were repeated to obtain a total of two independent trials.
3. Results and Discussion
The role of PTDM self-assembly in protein binding and delivery applications is unresolved.
We hypothesize that there are two main pathways by which PTDMs could bind protein cargo en route
to producing deliverable PTDM-protein complexes (Figure 1). One path involves PTDMs binding
protein as single chains and another involves PTDMs self-assembling prior to interacting with the
protein. Some surfactants are known to bind and denature protein, but we suspect that PTDMS do not
induce gross protein denaturation given that they have delivered functional protein intracellularly in
past reports [28,30,39]. In protein delivery applications, binding and PTDM-protein complex formation
takes placed in PBS prior to delivery, whereas delivery takes place in complete media, which includes
serum proteins. The focus of this communication is to understand self-assembly in the context of
the protein binding step. PTDM1 was selected as the model PTDM here due to its previous success
in protein binding and delivery applications. PTDM1 is also among the more hydrophobic variants
demonstrating intracellular protein delivery [20,21,29–31].
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the University of California, San Francisco (supported by NIGMS P41-GM103311).
. . I terf ci l ension (IFT)
o ascertain whether PTDMs have surfactant chara teristics, which ould pr mote self-ass mbly
in aqueous media, pendant drop interfacial tension (IFT) studies were conduct d in which an aqueous
droplet of Milli-Q® water, with 10% v/v DMSO, containing PTDM1 over a range of c ncentrations f
1, 10, and 100 µM, was suspended in a tol en ambient phase (Figure 2 and Figure S1–S5). The IFT
was measured over time until it r ached equilibrium for all samples (Figures S1–S5). The stable IFT
values in the equilibrium range, from at least two independent trials, were then averaged to generate
the one mean value plotted in Figure 2A. A control expe iment that measured the IFT of a Milli-Q®
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in agreement with literature values (Figure S1) [36,42]. A separate control in which the Milli-Q® water
droplet was made with 10% v/v DMSO showed that the presence of DMSO decreased the interfacial
tension by ~9 mN/m, but to a new stable equilibrium value (Figure S2). This control was necessary
because each PTDM1 solution tested also contained 10% v/v DMSO for consistency as the 100 µM
PTDM1 solution contained 10% v/v residual DMSO as a result of its sample preparation.
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water, Milli-Q® Water with 10% DMSO v/v (dark blue squares), or Milli-Q® Water with 10% DMSO
v/v and varying concentrations of PTDM1 (red squares) in a toluene ambient phase. Inset shows the
chemical structure of PTDM1. (B) Change in interfacial tension (∆IFT) between a control solution
containing no PTDM1 and solutions containing varying concentrations of PTDM1 (red solid squares).
Open data points were generated from literature values for a PS-PEO block copolymer or sodium
dodecyl sulfate (SDS) at various concentrations as compared to their respective control solutions [36,42].
∆IFT was calculated as IFTSample − IFTControl for all surfactants. The theoretical molecular weight for
PTDM1 is shown in the legend along with the calculated molecular weight of PS-PEO from literature.
Despite covering three orders of magnitude with respect to concentration, PTDM1 failed to act
as a strong surfactant resulting in only a slight decrease in IFT even at its highest concentration,
100 µM (Figure S5). One hundred µM is more than ten times higher than the concentration of PTDM1
that was present for binding EGFP cargo and forming complexes in a previous report [21]. Over the
application-relevant concentration range, 1 to 10 µM, the lack of surfactant character is evident. To fully
illustrate the poor surfactant nature of PTDM1, the change in IFT, calculated as ∆IFT = IFTsample −
IFTcontrol, was plotted in Figure 2B along with ∆IFT values calc late fro literature for the PS-PEO
block copolymer surfact nt and sodium do ecyl sulfate (SDS) (Table S1) [36,42]. Comparing PTDM1 to
the small molecule anionic surfa tant, SDS, over a similar concentration range highlights t at PTDM1 is
a worse surfactant than SDS. In fac , SDS has a litera ure-reported critical mic lle concen ration (CMC)
of ~8 mM [42]. This implies that PTDM1, being a worse surfactant, would have a higher CMC than
SDS and not assemble in the delivery r levant concentration range of 1–10 µM. Likewis , the standard
block copolymer surfactant PS-PEO decreases the IFT of a water-toluene interface much more than
SDS or PTDM1 at lower concentrations of <1 µM. The PS-PEO polymer surfactant from literature has
a significantly higher molecular weight than PTDM1, which could complicate direct comparisons.
That very observation, however, emphasizes the point that in order to be appreciably surface active
at low molar concentration, polymers seem to need to have higher molecular weights [33,36,43].
As for an example of a low molecular weight polymer surfactant, a PEO-PPO-PEO triblock, with Mn
~1460 g/mol and only 22 repeat units of PO and 4 repeat units of EO, was able to decrease the
IFT of a water-toluene interface by 19.9 mN/m, as compared to its control, at a concentration of
~6.85 mM. Other small PPO-PEO diblocks from the same study were similarly effective at decreasing
IFT in a similar mM concentration range (Table S1) [44]. These examples further illustrate the point
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that if a polymer surfactant has a low molecular weight, then it probably needs to be in higher
molar concentrations to be interfacially active. As such, PTDM1’s approximate molecular weight
(~6000 g/mol) is also low and could possibly account for PTDM1’s lack of interfacial activity at µM
level concentrations. Overall, our evaluation of the IFT data suggests that PTDM1 exists as a single
chain in water in the application-relevant concentration range of 1–10 µM and that it is not driven to
self-assemble on account of its poor surfactant nature.
3.2. Transmission Electron Microscopy (TEM)
TEM can be used to visualize self-assembled amphiphilic polymer structures even after drying
samples on grids [33,45]. For this reason, PTDM1 was studied by TEM to assess whether it is capable
of forming nanoscale or microscale aggregates. PTDM1 solutions at 10 µM in Milli-Q® water were
solvent cast onto TEM grids, had excess liquid removed, and were further dried in ambient conditions
overnight. Figure 3A–C shows large area TEM images of PTDM1, in which only large and small
drying artifacts can be seen. The process of drying the solutions likely caused the formation of the
large, irregularly shaped aggregates, which was expected. The small, dark black dots seen in the
images (example of one highlighted in Figure 3C) are standard small drying aggregates and not a
self-assembled morphology according to the TEM literature [46]. To illustrate this point, 1× PBS with
1% v/v DMSO was cast onto TEM grids and allowed to dry overnight. The PBS-only sample also
showed small black dot drying aggregates, demonstrating that this morphology could be reproduced
by drying a salt solution (Figure S7).
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It was difficult to find any evidence by TEM that PTDM1 had self-assembled into robust, stable 
structures capable of enduring the drying process. To alleviate the concern that TEM was incapable 
of visualizing material that had been solvent cast from low concentrations (0.06 mg/mL for PTDM1), 
another dried TEM sample was prepared with an IgG-FITC whole antibody (Ab) solution at a 
similarly low concentration of ~0.03 mg/mL. This sample resulted in the large area images shown in 
Figure 3D–F. The abundance of material seen in those large area images affirms that TEM is capable 
of detecting material residing on the grid at low concentrations. While the IgG-FITC solution did 
Figure 3. Transmission electron microscopy (TEM) micrographs of PTDM1 (A–C) and IgG-FITC whole
antibody (Ab) (D–F) solvent cast from Milli-Q® Water at 10 µM for PTDM1 and at 200 nM for the Ab on
TEM grids which were dried in ambient conditions overnight. (A) Large area image of PTDM1 in focus
showing large drying artifacts. (B) Large area image of PTDM1 at 2.50 µm under focus showing large,
medium, and small drying artifacts. (C) Large area image of PTDM1 at 2.50 µm under focus showing a
small drying artifact. (D) Large area image of Ab at 2.96 µm under focus showing an abundance of
aggregated material. (E) Large area image of Ab at 2.94 µm under focus showing a sparser region of
aggregated material. (F) Large area image of Ab in focus showing large drying aggregates.
It was difficult to find any evidence by TEM that PTDM1 had self-assembled into robust, stable
structures capable of enduring the drying process. To alleviate the concern that TEM was incapable of
visualizing material that had been solvent cast from low concentrations (0.06 mg/mL for PTDM1),
another dried TEM sample was prepared with an IgG-FITC whole antibody (Ab) solution at a similarly
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low concentration of ~0.03 mg/mL. This sample resulted in the large area images shown in Figure 3D–F.
The abundance of material seen in those large area images affirms that TEM is capable of detecting
material residing on the grid at low concentrations. While the IgG-FITC solution did contain small
amounts of residual salt from the commercially obtained protein solution, it is unlikely that those salts
led to the abundance of detectable material seen in Figure 3D–F, as the PBS-only TEM sample contained
significantly more salt and only resulted in the few small drying aggregates seen in Figure S7. The lack
of self-assembled structures in the TEM images corroborates the data from the IFT experiments
in that it supports the notion that PTDM1 is not prone to aggregate in aqueous environments at
application-relevant concentrations.
3.3. Dynamic Light Scattering (DLS) and Transmittance Assays (%T)
Dynamic light scattering (DLS) can be used to detect the presence of self-assembled polymer
aggregates and can also be used to indicate the absence of aggregates [16,33,34]. TEM and IFT
provided strong indications that PTDM1 is not prone to aggregate in water at low, application-relevant
concentrations, but to verify these observations, DLS and %T assays were conducted in water and also
in biologically relevant salt conditions using PBS (Figure 4). %T assays have been used by our group
previously to assess PTDM-protein complexation [31].
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Figure 4. Characterization of PTDM1 in aqueous solutions using transmittance (%T) assays and
dynamic light scattering (DLS). (A) %T of 700 nm light through solutions containing PTDM1 at 10 µM
in both Milli-Q® water (blue squares) and PBS (red circles). Results obtained are the average of two
independent trials where the average %T is plotted and the error bars represent ± one standard
deviation. (B) %T of 400 nm light through the same solutions containing PTDM1 at 10 µM in both
Milli-Q® water (blue squares) and PBS (red circles). Results obtained are the average of two independent
trials where the average %T is plotted and the err bars repr sent ± one standard deviatio . (C) DLS
correlation coefficient plots for two independent trials of PTDM1 at 10 µM in PBS where each trial run
was comprised of three measurements. Each sample was prepared immediately before the experiment.
(D) DLS correlation coefficient plots from two independent trials of PTDM1 at 10 µM in PBS that
had been stored in solution for ~24 h prior to measurements. Each trial run was comprised of three
measurements. (E) DLS correlation coefficient plots for three independent trials with 10 µM PTDM1
solutions in Milli-Q® water. Each trial run was comprised of three measurements. Each sample was
prepared immediately bef e the experiment. (F) DLS correl tion coefficient plots for thre independent
trials with 10 µM PTDM1 solutions in Milli-Q® water that had been stored in solution for ~24 h prior
to measurements. Each trial run was comprised of three measurements.
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To assess the potential for PTDM1 to aggregate in PBS, transmittance experiments were conducted
in which the transmittance (%T) of various wavelengths of light through PTDM1 solutions at 10 µM
were monitored over the course of ~24 h (Figure 4A,B, Figures S8 and S9). UV-Visible spectra were also
collected for PTDM1 at 10 µM to determine PTDM1’s absorbance profile (Figures S10 and S11). As seen
in Figure 4A, for PTDM1 in PBS, the %T of 700 nm light, which PTDM1 does not inherently absorb,
decreases over time compared to PTDM1 in water. This observation was suggestive of PTDM1’s ability
to aggregate in PBS if given enough time. The growth in either size or number of aggregates could
have accounted for the decrease in %T, but this interpretation was not definitive as a result of this
technique. The decrease in %T for PTDM1 in PBS over time and relative to PTDM1 in water was also
noted for smaller wavelengths of 300, 400, and 500 nm (Figure 4B, Figures S8 and S9). PTDM1 had
some absorbance at the smallest wavelengths tested, but the trends over time were the same. Since %T
provided an indication that aggregates could be forming, DLS measurements with PTDM1 solutions
were conducted.
When DLS experiments were conducted immediately following the preparation of PTDM1 10
µM PBS solutions, the results overall indicated a lack of detectable aggregates or self-assembled
structures on the basis of the poor correlation coefficient functions obtained (Figure 4C). Since the %T
data seemed to indicate that aggregation could occur over time, DLS experiments were conducted
again after a ~24 h waiting period with new PTDM1 solutions in PBS, during which time PTDM1
was stored in solution. For these samples, the results still indicated a lack of PTDM1 aggregates in
solution (Figure 4D). The absence of aggregates was also noted for PTDM1 at 10 µM in water solutions
whether DLS measurements were made immediately following sample preparation (Figure 4E) or after
a ~24 h waiting period for new samples during which time PTDM1 was stored in the water solution
(Figure 4F).
According to the DLS instrument manual, based on the potential size range of our polymer
“particle”, which is most likely a small, single chain, and the concentration at which the experiments
were conducted, there should be more than a sufficient number of “particles” or scatterers in the
scattering volume of the DLS sample. Although supposedly there was a sufficient number of scatterers,
they were clearly not large enough to scatter sufficient light to be detected, giving credence to the idea
that PTDM1 predominantly exists as single chains in aqueous media and not aggregates. Although the
%T data implies that PTDM1 could aggregate in PBS over time, this conclusion is not supported by
the data obtained by DLS. The %T assay is a bulk solution measurement through the whole sample,
however, which could better detect the presence of larger aggregates even if there were too few to be
observed by DLS. Most importantly, the %T data seems to indicate that aggregation, if it occurs at all,
only takes place over long time periods of at least 24 h. In terms of the application, protein binding
and delivery experiments take place over shorter time periods: 30 min for binding/complexation and
4 h for delivery.
Figure 5 shows the results of one trial of DLS titration experiments done with PTDM1
and IgG-FITC, where the addition of PTDM1 solution to the antibody solution resulted in a
shift in the size distribution by orders of magnitude throughout the course of the titration
(Figure 5B). The concentrations covered in the DLS titration can also be mapped onto similar
concentration points along a previously published antibody-PTDM1 binding curve re-plotted in
Figure 5A [31]. Taken together, the data show that increasing the PTDM concentration in the presence
of protein results in the initiation, formation, and growth of a complex as the previously published
fluorescence-quenching and %T data suggested. Figure 4 shows that PTDM1-only at 10 µM is
not assembled into an aggregate detectable by DLS. However, at a similar PTDM concentration,
in the presence of protein, an aggregate is formed, as evidenced by the robust correlation function
and corresponding size distribution plots (Figure S12). This observation supports the idea that
PTDM-protein complexes are brought about by protein-induced assembly and not self-assembly of the
PTDM at delivery experiment relevant concentrations.
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at PTDM1 = ~10 µM (step 2) and growth of the complex using increasing PTDM1 concentrations like
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The DLS dat of the antibody-only soluti th titrations are shown as a positive
control to further emphasize that the correlation functions obtained for the PTDM1-only solutions were
in fact noise and not indicative of a self-assembled aggregate (Figures S12 and S13). Changes in the
intensity-based size distribution plots at key points in the titration are also shown in the Supplementary
Materials along with all number-based size distribution plots at every step of the DLS titration for both
trials, highlighting that the overall trend is reproducible (Figures S12 and S14–S18).
4. Conclusions
Considering all data presented herein, PTDM1 does not aggregate or self-assemble in aqueous
media at application-relevant concentrations and time scales. Therefore, PTDM1 is more likely to
bind protein cargo as single chains than as aggregates. IFT and TEM together show that in simple
conditions without salt, PTDM1 is a poor surfactant and cannot form aggregates aside from mere
TEM grid drying artifacts. While there is some indication that PTDM1 has the potential to aggregate
in PBS by %T assays, aggregation could not be confirmed by DLS. As such, PTDM1 cannot readily
form robust aggregates capable of being detected by DLS furthering the conclusion that PTDM1 is not
inclined to aggregate or self-assemble prior to binding protein cargo in PBS. We argue instead that
PTDMs more likely bind protein cargo as single chains. Therefore, in line with the findings of our
related studies and with the results of the DLS experiments conducted within, the presence of protein
in solution with t e PTDM is required to induced complex formation. Future studies could eluci ate
whether the lack of self-assembly behavior applies to additional PTDMs with other side chains or
higher molecular weights. Additi nally, protein-induced complex as embly could be studied for other
combinations of PTDMs and protein cargoes to assess the general applicability of this observation.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4360/10/9/1039/
s1, Figure S1: Three independent trials of pendant drop interfacial tension (IFT) raw data for Milli-Q® water
droplet in a Toluene ambient phase, Figure S2: Three independent trials of pendant drop interfacial tension
(IFT) raw data for Milli-Q® water with 10% v/v DMSO droplet in a Toluene ambient phase, Figure S3: Three
independent trials of pendant drop interfacial tension (IFT) raw data for PTDM1 1 µM in Milli-Q® water with 10%
v/v DMSO droplet in a Toluene ambient phase, Figure S4: Two independent trials of pendant drop interfacial
tension (IFT) raw data for PTDM1 10 µM in Milli-Q® water with 10% v/v DMSO droplet in a Toluene ambient
phase, Figure S5: Two independent trials of pendant drop interfacial tension (IFT) raw data for PTDM1 100 µM in
Milli-Q® water with 10% v/v DMSO droplet in a Toluene ambient phase, Figure S6: Comparison of surfactants
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from literature (SDS and PS-PEO) and PTDM1 with respect to their ability to decrease IFT, denoted as ∆IFT, at a
water-toluene interface, Figure S7: TEM micrograph of 1× PBS solution with 1% v/v DMSO that was solvent cast
onto a TEM grid followed by removal of excess liquid and drying at ambient conditions overnight, Figure S8: %T
of 300 nm light through solutions containing PTDM1 at 10 µM in both Milli-Q® water (blue squares) and PBS
(red circles), Figure S9: %T of 500 nm light through solutions containing PTDM1 at 10 µM in both Milli-Q® water
(blue squares) and PBS (red circles), Figure S10: UV-visible spectra of PTDM1 in water and PBS along with control
solutions of water-only and PBS-only, Figure S11: UV-visible spectra of PTDM1 in water and PBS along with
control solutions of water-only and PBS-only, Figure S12: Dynamic Light Scattering (DLS) titration experiment
representative overview showing: (A) Correlation coefficient function for PTDM1-only at 10 µM in PBS (shown
again for comparison), Figure S13: Dynamic Light Scattering (DLS) data showing correlation coefficient functions
for IgG-FITC antibody (Ab) at 200 nM in PBS with their corresponding intensity-based size distributions, Figure
S14: DLS titration data from a second trial of the DLS titration experiment showing correlation functions (left),
individual intensity-based size distributions from the results of the three measurements taken per sample (middle),
and the averaged intensity-based size distributions shown with ± one standard deviation obtained from the
three individual measurements taken of the sample per this second trial, Figure S15: DLS titration data showing
number-based size distribution plots (3 measurements per sample) for the starting solution of antibody-only for
the two trials, Figure S16: DLS titration data showing number-based size distribution plots (3 measurements
per sample) for each step of the titration where the total volume of PTDM1 1 mM DMSO stock solution that
had been added up to that point is shown above the plot for both trials, Figure S17: DLS titration data showing
number-based size distribution plots (3 measurements per sample) for each step of the titration where the total
volume of PTDM1 1 mM DMSO stock solution that had been added up to that point is shown above the plot
for both trials, Figure S18: DLS titration data showing number-based size distribution plots (3 measurements
per sample) for each step of the titration where the total volume of PTDM1 1 mM DMSO stock solution that
had been added up to that point is shown above the plot for both trials., Table S1: IFT values for PTDM1 and
surfactants from literature used for creating comparison plots, Table S2: DLS titration experiment concentrations
and additions summary table.
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